Belarus vs Republic of Moldova: The number of people with susceptibility test result for rifampicin
Belarus
1,032
in 2021
Republic of Moldova
991
in 2021
Belarus rank
66th
Republic of Moldova rank
67th
The number of people with susceptibility test result for rifampicin over time
- Belarus
- Republic of Moldova
How they compare
Belarus currently reports 1,032 against 991 in Republic of Moldova, a difference of 41.
Across all 5 years both countries report, Belarus has been ahead every year.
Belarus ranks 66th and Republic of Moldova ranks 67th of 155 countries.
Belarus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belarus | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,570 | 1,394 | 175.33 | Belarus |
| 2020s | 1,024 | 915.5 | 108 | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belarus or Republic of Moldova?
- Belarus, at 1,032 against 991 in Republic of Moldova as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belarus and Republic of Moldova?
- 41, with Belarus ahead.
- How many years of comparable data are there for Belarus and Republic of Moldova?
- 5 years are reported by both, from 2017 to 2021.
- How do Belarus and Republic of Moldova rank globally for the number of people with susceptibility test result for rifampicin?
- Belarus ranks 66th and Republic of Moldova ranks 67th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.